Clinical Services

May 2020

500 Pathways Live! Celebrating a HealthPathways Milestone

21/5/20

 

The recently published COVID-19 response package and a first suite of Palliative Care pathways released led Western Sydney HealthPathways to reach another milestone - 500 localised live health pathways!


Usage of Western Sydney HealthPathways by General Practitioners varies from 750 to 1060 each month. More than 130,000 pathway pages were viewed in the past 12 months.


HealthPathways aims to improve the management of patients in and between primary and secondary care, through clearly defined pathways and protocols, as well as improving communication between clinicians. This resource assists in referring patients to the right place at the right time, the first time to access appropriate services and care without unnecessary process delays.


The Western Sydney HealthPathways team would like to thank the 600 plus Subject Matter Experts from Western Sydney Local Health District and the Sydney Children’s Hospital Network Westmead, for their support, collaboration and expert contributions to localise these pathways.


Access HealthPathways via:

 

Contact for more information 

Julianne Bogdanovski

0408 415 923

julianne.bogdanovski@health.nsw.gov.au

 

Submitted by Julianne Bogdanovski

Management of Anticoagulation for Patients Undergoing Procedures

21/5/20

 

The WSLHD Perioperative Management of Anticoagulation for Adult Patients Undergoing Surgical or Medical Procedures Guideline (version 1.0) has been recently approved and published. It is now available via the Policy and Procedures Portal.

This document provides guidance for anticoagulation for adult patients (over 16 years of
age) undergoing surgery or medical procedures in Western Sydney Local Health District
(WSLHD).

It is based upon the NSW Clinical Excellence Commission (CEC) Guidelines on Perioperative Management of Anticoagulant and Antiplatelet Agents (updated December 2018).

Contact for more information 

Dr Jennifer Curnow

via Switch

WSLHD-DrugCommittee@health.nsw.gov.au

Submitted by Marcelle Appay

Change of Intravenous Heparin APTT Therapeutic Ranges from 4 May 2020

21/5/20

 

From 11.00 am on 4 May, the APTT is measured with new reagents and therefore the APTT therapeutic/target ranges for monitoring therapy with intravenous (IV) unfractionated heparin (UFH) will change.

As a result, the WSLHD Anticoagulation (Adult) Guidelines version 12.0 have been revised to reflect the new APTT therapeutic ranges. Please refer to the published electronic guidelines on the Policy and Procedures Portal for the latest version.

The reference texts in the eMeds Heparin Powerplans have also been updated to reflect the new APTT therapeutic range for IV unfractionated heparin.

Contact for more information 

Dr Jenny Curnow

via switch

WSLHD-DrugCommittee@health.nsw.gov.au

Submitted by Marcelle Appay

Copyright © 2019 Western Sydney Local Health District 

Disclaimer: Information in The Regular Dose is intended for WSLHD staff. As a recipient of The Regular Dose you are not permitted to disseminate
or distribute The Regular Dose to any third party outside WSLHD. Any such act may constitute a breach of the WSLHD Code of Conduct.